Patient adherence to therapy after switch to aflibercept from bevacizumab or ranibizumab for treatment‑refractory neovascular age‑related macular degeneration.

Autor:	Archambault, Simon D.1,2, Nichols, Megan M.1,2, McCullum, James C.1,2, Yubo Zhang1,3, Steinberger, Elise E.1,2, Ramsey, David J.1,2 David.J.Ramsey@lahey.org
Zdroj:	Indian Journal of Ophthalmology. 2024 Supplement, Vol. 72, pS101-S105. 5p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu